Standardized Whole-Blood Assays for Immunometabolism
2026-08-19
The reference study presents a standardized whole-blood stimulation protocol for testing how metabolic interventions reshape human immune responses. By combining defined immune stimuli, pathway-directed inhibitors, and cytokine measurements, the workflow supports scalable immunometabolism studies while preserving the cellular interactions found in whole blood.
25-Hydroxycholesterol Reprograms Tumor Macrophages
2026-08-18
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that links lysosomal lipid sensing to AMPKα–STAT6 signaling and immunosuppressive macrophage function. The study provides a mechanistic framework for understanding how tumor-associated macrophages regulate T-cell exclusion and how CH25H targeting may improve responses to anti-PD-1 therapy.
From HA Tags to Translational Mechanism
2026-08-18
The Influenza Hemagglutinin (HA) Peptide is more than an elution reagent: it can strengthen the experimental chain connecting tagged-protein biochemistry to mechanistic and translational claims. This article links HA-tag workflow design with the NEDD4L–PRMT5–AKT/mTOR findings reported in Advanced Science, while defining the opportunities and limits of cross-domain application.
Gastrin I: Applied Workflow for GI Research
2026-08-17
Build more reproducible gastric acid secretion pathway research with a defined human Gastrin I peptide workflow spanning receptor assays, organoids, and gastrointestinal disorder research. This guide emphasizes formulation, dose-response design, model selection, and practical troubleshooting rather than treating one assay format as universally applicable.
Olive Biophenols and Alzheimer’s Pathology
2026-08-17
The reference study combines amyloid aggregation assays, SH-SY5Y neuroblastoma experiments, and an APPswe/PS1dE9 mouse model to examine olive-derived biophenols as modulators of Alzheimer’s-related pathology. Oleuropein, verbascoside, and rutin showed anti-amyloidogenic or protective activity, while olive leaf extract reduced plaque deposition in mouse cortex and hippocampus, although bioavailability and blood–brain barrier transfer remain unresolved.
TDRD9 siRNA Nanoparticles in Pseudomonas Lung Injury
2026-08-16
This study identifies TDRD9 as a regulator of neutrophil cuproptosis during Pseudomonas aeruginosa lung infection and develops hyaluronic acid-coated peptide nanoparticles for siRNA delivery. Across patient-derived samples, mouse models, adoptive-transfer experiments, and human lung organoids, TDRD9 silencing reduced pulmonary injury while improving infection-associated outcomes through the PD-L1/CD80/p38 MAPK axis.
SAR405: Decoding Vps34 Under Energy Stress
2026-08-15
SAR405 is a selective Vps34 inhibitor for separating autophagy initiation from downstream membrane and lysosome phenotypes. This guide translates recent AMPK–ULK1 findings into practical assay design for autophagy inhibition, vesicle trafficking modulation, and cancer research.
Parthenolide, ROS, and Lymphoid Malignancies
2026-08-15
Jorge and colleagues integrated resazurin-based metabolic profiling with flow cytometry and gene-expression analysis to examine how parthenolide affects diverse lymphoid malignancy models. The study links reduced metabolic activity to apoptosis, oxidative stress, glutathione depletion, and mitochondrial dysfunction while showing that downstream mechanisms vary between cell lines.
Ferrostatins and Oxidative Lipid Cell Death
2026-08-14
Skouta and colleagues established ferrostatin-1 as a potent inhibitor of ferroptosis that protects cells by suppressing oxidative lipid damage rather than broadly eliminating reactive oxygen species. Their cross-model experiments connected lipid peroxidation with cell death in Huntington’s disease, periventricular leukomalacia, and kidney injury models, while mechanistic and structure–activity studies guided improved ferrostatin design.
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-14
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed for higher-resolution separation of low-molecular-weight proteins and peptides that may be poorly resolved by conventional Tris-SDS-PAGE. It is intended for research protein electrophoresis and peptide separation, not for diagnostic, clinical, or medical use.
CDK9 inhibitor A3294: Practical Protocol Guide
2026-08-13
CDK9 inhibitor (A3294) provides selective inhibition of cyclin-dependent kinase 9 for studies of transcription elongation, P-TEFb function, and HIV-1 propagation. It is not intended as a broad-spectrum CDK inhibitor, a general cell cycle regulation tool, or a reagent requiring long-term storage of prepared solutions.
Budesonide Workflows for Lung Permeability Research
2026-08-13
Build more informative asthma inflammation models by pairing Budesonide’s anti-inflammatory activity with biomimetic membrane-permeability screening. This workflow shows when to use IAM-LC, OT-CEC-MS, and cell-based validation, while addressing solubility, coating stability, matrix effects, and vehicle control.
Fangchinoline Restores Lysosomal Biogenesis in H1N1
2026-08-12
The reference study identifies fangchinoline as a host-directed antiviral compound that restores TFEB-dependent lysosomal biogenesis and interferes with H1N1 entry. Its combination of Connectivity Map screening, organelle-level assays, time-resolved infection experiments, and in vivo validation provides a mechanistic framework for targeting lysosomal dysfunction during influenza infection.
Fast HepaRG Differentiation for HBV and HDV Studies
2026-08-12
Lucifora and colleagues developed a five-chemical strategy that produces infection-competent HepaRG cells after one week, enabling HDV studies without the conventional four-week differentiation period. The protocol supports HDV entry and replication but yields weaker HBV cccDNA formation and downstream replication, making it a useful rapid model with important virus-specific limitations.
Bestatin (Ubenimex): An Assay-First Guide
2026-08-11
Bestatin, also known as Ubenimex, is a structurally informative aminopeptidase inhibitor for dissecting proteolysis, multidrug resistance, and cancer-cell phenotypes. This assay-first guide explains how to interpret its potency, selectivity, cellular use, and translational limitations without confusing enzyme inhibition with downstream biological outcomes.
459 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page